Cerevel Therapeutics Holdings, Inc.
CERE
Ранг среди акций
#2812
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical firm... Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing treatments for a range of neuroscience disorders. The company boasts a robust pipeline of therapeutic candidates currently undergoing various phases of clinical evaluation. Key assets include emraclidine, a positive allosteric modulator (PAM) in Phase 1b trials for schizophrenia. Another PAM, Darigabat, is being assessed in a Phase 2 proof-of-concept study for drug-resistant focal onset seizures in epilepsy, as well as in a Phase 1 trial for acute anxiety. For Parkinson's disease, Cerevel is advancing Tavapadon, a selective dopamine D1/D5 partial agonist, through Phase 3 clinical trials for both early and late stages of the condition. A related compound, CVL-871, also a selective dopamine D1/D5 partial agonist, is in Phase 2a trials for dementia-related apathy. The company's portfolio further includes CVL-936, a selective dopamine D3-preferring antagonist in Phase I for substance use disorder; CVL-354, a selective kappa-opioid receptor antagonist targeting major depressive disorder and substance use disorder; and CVL-047, a selective PDE4 inhibitor also aimed at major depressive disorder and substance use disorder. Beyond individual compounds, Cerevel is actively developing an M4 agonist program for psychosis and related indications, alongside an LRRK2 inhibitor program designed to address the progression of Parkinson's disease. Founded in 2018, Cerevel Therapeutics is headquartered in Cambridge, Massachusetts.
Цена акции
$44.96
Последняя синхронизация: 2024-08-01
Рыночная капитализация
$6.67B
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Cerevel Therapeutics Holdings, Inc. (CERE)
Категория
Healthcare
История дроблений акций Cerevel Therapeutics Holdings, Inc. (CERE)
Акции Cerevel Therapeutics Holdings, Inc. (символ: CERE) прошли через 0 дроблений.
Последнее дробление произошло Oct 20, 2026.
Одна акция CERE, купленная до Oct 20, 2026, сейчас соответствует 0 акциям CERE.
Последнее дробление произошло Oct 20, 2026.
Одна акция CERE, купленная до Oct 20, 2026, сейчас соответствует 0 акциям CERE.
Список дроблений акций
| Год | Дробление | Коэффициент | Суммарный коэффициент |
|---|---|---|---|
| Недостаточно данных для указанных дат. | |||
Дробления акций аналогичных компаний или конкурентов
| Компания | Количество дроблений акций | Суммарный коэффициент | Страна |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
